Received: 2025-09-29
Accepted: 2025-12-06
Published: 2026-01-01
Pages: 57-62
Periodontal disease is a chronic inflammatory disorder resulting from the dynamic interplay of pathogenic bacteria within the oral microbiota and host defense, ultimately leading to alveolar bone loss, tooth mobility, and tooth exfoliation. Conventional periodontal treatments (mechanical debridement and adjunctive antimicrobial agents) essentially control established disease, without offering lifelong protective immunity against relevant periodontopathogens. Periodontal vaccination is a new immunotherapeutic approach for inducing the host to generate an immune response toward certain bacterial virulence factors so that colonization and tissue destruction of periodontopathic bacteria in hosts are inhibited. Diverse kinds of vaccines, such as whole cell, subunit, recombinant protein, DNA and conjugate vaccines have been studied for their potential to elicit humoral and cellular immune responses. Preclinical trials in animal models have shown some positive outcomes, including reduction of bacterial load, inhibition of alveolar bone loss, and systemic as well as mucosal immune responses. Gingipain subunit and fimbrial Porphyromonas gingivalis DNA vaccines have provided particularly encouraging results. However, limitations such as the polymicrobial nature of periodontitis, interindividual differences in immune responses, safety issues and lack of human clinical trials still exist. These limitations can be potentially overcome by focusing on the mucosal delivery systems, nanoparticle-based vaccines, multivalent formulations and personalized immunotherapy in future studies. Periodontal vaccination is a novel concept of preventive dentistry, which shifts the current treatment model to prophylactic methods based on immune-mediated disease prevention and life-long maintenance of periodontal as well as overall health.
Keywords: Alveolar bone loss, DNA vaccine, Periodontitis, Subunit vaccine, Vaccination
1. Hashim NT et al. Int J Environ Res Public Health. 2025 Apr 16;22(4):624. [DOI: 10.3390/ijerph22040624]
2. Petersen PE et al. Periodontol 2000. 2012 Oct;60(1):15-39. [DOI: 10.1111/j.1600-0757.2011.00425.x]
3. Tariq M et al. Int J Pharm Investig. 2012 Jul;2(3):106-22. [DOI: 10.4103/2230-973X.104394]
4. Patel P et al. Cureus. 2025 Mar 15;17(3):e80636. [DOI: 10.7759/cureus.80636]
5. Vaernewyck V et al. Front Immunol. 2021 Dec 2;12:768397. [DOI: 10.3389/fimmu.2021.768397]
6. Kudyar N et al. J Indian Soc Periodontol. 2011 Apr;15(2):115-20. [DOI: 10.4103/0972-124X.84378]
7. Janakiram C et al. Periodontol 2000. 2020 Oct;84(1):202-214. [DOI: 10.1111/prd.12337]
8. Sharma DC et al. Expert Rev Vaccines. 2007 Aug;6(4):579-90. [DOI: 10.1586/14760584.6.4.579]
9. Bertani B et al. EcoSal Plus. 2018 Aug;8(1):10.1128/ecosalplus.ESP-0001-2018. [DOI: 10.1128/ecosalplus.ESP-0001-2018]
10. Brazzoli M et al. Hum Vaccin Immunother. 2023 Aug 1;19(2):2228669. [DOI: 10.1080/21645515.2023.2228669]
11. Vinayaka AM. J Dent Panacea. 2024;6(1):20-25. [DOI: 10.18231/j.jdp.2024.006]
12. Ebersole JL et al. Periodontol 2000. 2013 Jun;62(1):163-202. [DOI:10.1111/prd.12005]
13. Nazir MA. Int J Health Sci (Qassim). 2017 Apr-Jun;11(2):72-80. [PMID: 28539867]
14. Etminan S et al. Front Med (Lausanne). 2025 Jul 17;12:1619845. [DOI: 10.3389/fmed.2025.1619845]
15. S. Aadil Ahamed et al. Research J. Pharm. and Tech. 2016; 9(7):972-976. [DOI: 10.5958/0974-360X.2016.00186.4]
16. Choi JI et al. J Periodontal Implant Sci. 2010 Aug;40(4):153-63. [DOI: 10.5051/jpis.2010.40.4.153]
17. Hu W et al. J Adv Res. 2025 Jul;73:443-458. [DOI: 10.1016/j.jare.2024.08.019]
18. Jia L et al. Front Cell Infect Microbiol. 2019 Jul 18;9:262. [DOI: 10.3389/fcimb.2019.00262]
19. Malhotra Ranjan et al. Indian Journal of Dental Research 22(5): p 698-705, Sep–Oct 2011. [DOI: 10.4103/0970-9290.93459]
20. Laupèze B et al. NPJ Vaccines. 2021 Jul 27;6(1):93. [DOI: 10.1038/s41541-021-00354-z]
21. Hou Y et al. Acta Pharm Sin B. 2023 Aug;13(8):3321-3338. [DOI: 10.1016/j.apsb.2023.01.006. Epub 2023 Jan 10]
22. Wang M et al. Bioengineered. 2016 Apr;7(3):155-65. [DOI: 10.1080/21655979.2016.1191707].
23. Khan KH. Germs. 2013 Mar 1;3(1):26-35. [DOI: 10.11599/germs.2013.1034]
24. Rappuoli R et al. Proc Natl Acad Sci U S A. 2019 Jan 2;116(1):14-16. [DOI: 10.1073/pnas.1819612116]
25. Dhingra K et al. J Periodontol. 2010 Nov;81(11):1529-46. [DOI: 10.1902/jop.2010.100138]
26. Yonezawa H et al. Infect Immun. 2001 May;69(5):2858-64. [DOI: 10.1128/IAI.69.5.2858-2864.2001]
27. Su F et al. Hum Vaccin Immunother. 2016 Apr 2;12(4):1070-9. [DOI: 10.1080/21645515.2015.1114195]
28. Fal Dessai et al. International Journal Of Drug Research And Dental Science, 5(3), 1-10. [DOI: 10.36437/ijdrd.2023.5.3.A]
29. Pattanshetty et al. Journal of Multidisciplinary Dental Research.2018:4(1);48-55. [Available from: https://jmdr-idea.com/articles/periodontal-vaccine-a-review]
30. Jain P et al. Pharmaceutics. 2021 Jul 30;13(8):1175. [DOI: 10.3390/pharmaceutics13081175]
31. Cancan Huang et al. EngMedicine, Volume 2, Issue 1, March 2025, 100052 [DOI: 10.1016/j.engmed.2024.100052]
32. Liao L et al. Int Immunopharmacol. 2024 Oct 25;140:112650. Epub 2024 Jul 29. Erratum in: Int Immunopharmacol. 2025 Aug 28;161:115093. [DOI: 10.1016/j.intimp.2024.112650].
33. Olivieri B et al. Vaccines (Basel). 2021 Jul 22;9(8):815. [DOI: 10.3390/vaccines9080815]
34. Săndulescu O et al. Germs. 2023 Jun 30;13(2):104-107. [DOI: 10.18683/germs.2023.1373]
35. Yusuf H et al. Hum Vaccin Immunother. 2017 Jan 2;13(1):34-45. [DOI: 10.1080/21645515.2016.1239668]. Epub 2016 Dec 9.
36. Loeurng V et al. Vaccines (Basel). 2024 Jul 8;12(7):754. [DOI: 10.3390/vaccines12070754]